5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.62▲ | 0.62▲ | 0.62▲ | 0.65▼ | 0.66▼ |
MA10 | 0.62▲ | 0.63▲ | 0.63▲ | 0.62▲ | 0.75▼ |
MA20 | 0.62▲ | 0.63▼ | 0.64▼ | 0.65▼ | 0.77▼ |
MA50 | 0.63▼ | 0.66▼ | 0.63▼ | 0.74▼ | 1.42▼ |
MA100 | 0.66▼ | 0.62▲ | 0.64▼ | 0.78▼ | 1.35▼ |
MA200 | 0.64▼ | 0.69▼ | 0.75▼ | 1.27▼ | 9.69▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.000▲ | -0.003▼ | 0.008▲ | 0.021▲ |
RSI | 51.054▲ | 46.909▼ | 46.736▼ | 44.056▼ | 37.586▼ |
STOCH | 35.277 | 17.352▼ | 31.267 | 50.206 | 30.360 |
WILL %R | -56.677 | -56.677 | -60.541 | -60.023 | -74.655 |
CCI | 53.221 | 25.165 | -9.058 | -2.769 | -55.168 |
Tuesday, June 10, 2025 02:31 PM
$CNTX insiders have traded $CNTX stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales. We have seen 8 ...
|
Tuesday, June 10, 2025 04:10 AM
Context Therapeutics offers a compelling long opportunity, with three differentiated bispecific T-cell engagers. Click here to see why CNTX stock is a Buy.
|
Monday, June 02, 2025 04:30 AM
PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 0.6287 | 0.64 | 0.6113 | 0.6294 | 171,138 |
12/06/25 | 0.658 | 0.658 | 0.62 | 0.6526 | 272,811 |
11/06/25 | 0.72 | 0.72 | 0.60 | 0.6203 | 1,498,414 |
10/06/25 | 0.7315 | 0.7315 | 0.6534 | 0.6549 | 381,166 |
09/06/25 | 0.8387 | 0.8387 | 0.662 | 0.7029 | 1,111,218 |
06/06/25 | 0.56 | 0.6983 | 0.5501 | 0.6641 | 400,378 |
05/06/25 | 0.58 | 0.5996 | 0.5439 | 0.5516 | 291,219 |
04/06/25 | 0.5784 | 0.5978 | 0.5215 | 0.5753 | 101,392 |
03/06/25 | 0.60 | 0.6299 | 0.5334 | 0.582 | 404,634 |
02/06/25 | 0.60 | 0.6298 | 0.52 | 0.588 | 232,793 |
|
|
||||
|
|
||||
|
|